TY - JOUR
T1 - Long-term results of proton beam therapy for carcinoma of the uterine cervix
AU - Kagei, Kenji
AU - Tokuuye, Koichi
AU - Okumura, Toshiyuki
AU - Ohara, Kiyoshi
AU - Shioyama, Yoshiyuki
AU - Sugahara, Shinji
AU - Akine, Yasuyuki
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2003/4/1
Y1 - 2003/4/1
N2 - Purpose: To determine the role of proton therapy in patients with carcinoma of the uterine cervix. Methods and Materials: Between 1983 and 1991, 25 patients with squamous cell carcinoma of the uterine cervix (stages IIB-IVA) were treated with a curative intent by external photon irradiation to the pelvis, followed by proton irradiation to the primary tumor, delivering a median total tumor dose of 86 Gy (range 71 Gy/26 Fr-101 Gy/46 Fr), and were followed for a median period of 139 months (range 11-184 months). Results: Ten-year overall survival rates for stages IIB and IIIB/IVA patients were 89% and 40%, respectively. Five-year local control rates for stages IIB and IIIB/IVA patients were 100% and 61%, respectively. Four percent of patients experienced severe (Grade 4 or more) late complications in the intestine or urinary bladder at 5 years. Conclusions: External photon and proton therapy is effective for those who are not eligible for intracavitary irradiation, and who otherwise have a poor prognosis. The results show that tumor control, survival, and morbidity are similar to those after conventional therapy.
AB - Purpose: To determine the role of proton therapy in patients with carcinoma of the uterine cervix. Methods and Materials: Between 1983 and 1991, 25 patients with squamous cell carcinoma of the uterine cervix (stages IIB-IVA) were treated with a curative intent by external photon irradiation to the pelvis, followed by proton irradiation to the primary tumor, delivering a median total tumor dose of 86 Gy (range 71 Gy/26 Fr-101 Gy/46 Fr), and were followed for a median period of 139 months (range 11-184 months). Results: Ten-year overall survival rates for stages IIB and IIIB/IVA patients were 89% and 40%, respectively. Five-year local control rates for stages IIB and IIIB/IVA patients were 100% and 61%, respectively. Four percent of patients experienced severe (Grade 4 or more) late complications in the intestine or urinary bladder at 5 years. Conclusions: External photon and proton therapy is effective for those who are not eligible for intracavitary irradiation, and who otherwise have a poor prognosis. The results show that tumor control, survival, and morbidity are similar to those after conventional therapy.
UR - http://www.scopus.com/inward/record.url?scp=0037376119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037376119&partnerID=8YFLogxK
U2 - 10.1016/S0360-3016(02)04075-0
DO - 10.1016/S0360-3016(02)04075-0
M3 - Article
C2 - 12654436
AN - SCOPUS:0037376119
SN - 0360-3016
VL - 55
SP - 1265
EP - 1271
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 5
ER -